Policy Brief
Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases
Nicholas R. Harrison & Sarah Sheehan
2020
Read MoreEducation Resource
Policy Brief
Nicholas R. Harrison & Sarah Sheehan
2020
Read MoreEducation Resource